Evidence map›Paper›PMID 24157919›Full record

ArticleNature communications2013

Bod1 regulates protein phosphatase 2A at mitotic kinetochores.

Iain M Porter, Katharina Schleicher, Michael Porter, Jason R Swedlow

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Review
  3. Upregulated inwardly rectifying KJournal of biomedical research · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Iain M PorterCentre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.
Katharina Schleicher
Michael Porter
Jason R Swedlow
University of Dundee · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H013024/1Cancer Research UK C303/A5434Cancer Research UK C5314/A11784Wellcome Trust 067433Wellcome Trust 095931Wellcome Trust 095931/Z/11/ZWellcome Trust 097945Wellcome Trust 097945/B/11/Z
6 · The paper itself

Abstract

Mitotic entry and progression require the activation of several mitotic kinases and the proper regulation and localization of several phosphatases. The activity and localization of each of these enzymes is tightly controlled through a series of specific activators, inhibitors and regulatory subunits. Two proteins, Ensa and Arpp-19, were recently identified as specific inhibitors of PP2A-B55 and are critical for allowing full activity of Cdk1/cyclin B and entry into mitosis. Here we show that Bod1, a protein required for proper chromosome alignment at mitosis, shares sequence similarity with Ensa and Arpp-19 and specifically inhibits the kinetochore-associated PP2A-B56 holoenzyme. PP2A-B56 regulates the stability of kinetochore-microtubule attachments by dephosphorylating several kinetochore proteins. Loss of Bod1 changes the balance of phosphorylation at kinetochores, causing defects in kinetochore function. Bod1, Ensa and Arpp-19 define a family of specific PP2A inhibitors that regulate specific PP2A holoenzymes at distinct locations and points in the cell cycle.

Indexed as

MitosisAmino Acid SequenceCDC2 Protein KinaseCell Cycle ProteinsChromosomes, HumanCyclin BGene Expression RegulationHeLa CellsHumansKinetochoresMicroscopy, FluorescenceMicrotubulesMolecular Sequence DataPhosphoproteinsPhosphorylationProtein Phosphatase 2Bod1 protein, humanCDC2 Protein KinaseCell Cycle Proteinscyclic AMP-regulated phosphoprotein 19Cyclin BPhosphoproteinsProtein Phosphatase 2Protein Subunits

Identifiers

PMID24157919
PMCPMC3826647
OpenAlexW2114039383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.